PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy
Authors
Keywords
Human immunodeficiency virus, Positron emission tomography, Magnetic resonance imaging, HIV-associated neurocognitive impairment
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 44, Issue 5, Pages 895-902
Publisher
Springer Nature
Online
2017-01-05
DOI
10.1007/s00259-016-3602-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuroinflammation in treated HIV-positive individuals
- (2016) Jaime H. Vera et al. NEUROLOGY
- In Vivo Measurement of GABA Transmission in Healthy Subjects and Schizophrenia Patients
- (2015) W. Gordon Frankle et al. AMERICAN JOURNAL OF PSYCHIATRY
- Positron-emission tomography molecular imaging of glia and myelin in drug discovery for multiple sclerosis
- (2015) Paul M Matthews et al. Expert Opinion on Drug Discovery
- Role of HIV in Amyloid Metabolism
- (2014) Mario Ortega et al. Journal of Neuroimmune Pharmacology
- Regional brain distribution of translocator protein using [11C]DPA-713 PET in individuals infected with HIV
- (2014) Jennifer M. Coughlin et al. JOURNAL OF NEUROVIROLOGY
- Early detection of Alzheimer's disease using PiB and FDG PET
- (2014) Ann D. Cohen et al. NEUROBIOLOGY OF DISEASE
- Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART
- (2013) Lucy J. Garvey et al. AIDS
- 18F-FDG PET/CT in HIV-related central nervous system pathology
- (2013) Scarlett Lewitschnig et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prevalence of HIV and chronic comorbidities among older adults
- (2012) Joel Negin et al. AIDS
- Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers
- (2012) Virawudh Soontornniyomkij et al. AIDS
- 11C-PiB Imaging of Human Immunodeficiency Virus–Associated Neurocognitive Disorder
- (2012) Beau M. Ances ARCHIVES OF NEUROLOGY
- Differential Cognitive Impairment in HCV Coinfected Men With Controlled HIV Compared to HCV Monoinfection
- (2012) Bing Sun et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation
- (2012) William C Kreisl et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients
- (2012) Pierfrancesco Grima et al. JOURNAL OF INFECTION
- Cerebral FDG-PET scanning abnormalities in optimally treated HIV patients
- (2012) Åse B Andersen et al. Journal of Neuroinflammation
- Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections
- (2012) Jan Jessen Krut et al. JOURNAL OF NEUROLOGY
- Antiretroviral neurotoxicity
- (2012) Kevin Robertson et al. JOURNAL OF NEUROVIROLOGY
- Identifying improved TSPO PET imaging probes through biomathematics: The impact of multiple TSPO binding sites in vivo
- (2012) Qi Guo et al. NEUROIMAGE
- Superior neurocognitive function is associated with central nervous system antiretroviral drug penetration only in regimens containing more than three antiretroviral agents
- (2011) Alan Winston et al. AIDS
- FDG PET/CT in Patients With HIV
- (2011) Jessica M. Davison et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Low Rates of Neurocognitive Impairment Are Observed in Neuro-Asymptomatic HIV-Infected Subjects on Effective Antiretroviral Therapy
- (2011) Lucy Garvey et al. HIV CLINICAL TRIALS
- An 18-kDa Translocator Protein (TSPO) Polymorphism Explains Differences in Binding Affinity of the PET Radioligand PBR28
- (2011) David R Owen et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Does Choice of Combination Antiretroviral Therapy (cART) Alter Changes in Cerebral Function Testing after 48 Weeks in Treatment‐Naive, HIV‐1–Infected Individuals Commencing cART? A Randomized, Controlled Study
- (2010) Alan Winston et al. CLINICAL INFECTIOUS DISEASES
- Mixed-Affinity Binding in Humans with 18-kDa Translocator Protein Ligands
- (2010) D. R. J. Owen et al. JOURNAL OF NUCLEAR MEDICINE
- Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: A case-control study
- (2010) B. M. Ances et al. NEUROLOGY
- HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study
- (2010) R. K. Heaton et al. NEUROLOGY
- Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance
- (2009) Christina M Marra et al. AIDS
- Amyloid and tau cerebrospinal fluid biomarkers in HIV infection
- (2009) Magnus Gisslén et al. BMC Neurology
- CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease
- (2009) D. B. Clifford et al. NEUROLOGY
- Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers
- (2008) Fabien Chauveau et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse
- (2008) Linda Chang et al. NEUROIMAGE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation